Ground Truth Labs
Ground Truth Labs (GTL) is an AI-driven company focused on decoding disease in the bone marrow. Their platform quantifies established markers and uncovers novel morphological patterns predictive of outcomes in blood cancers. GTL's technology analyzes bone marrow tissue at both slide and cell levels to measure features like fibrosis, megakaryocytes, blasts, and plasma cells, streamlining analysis and enhancing reproducibility. Their AI discovery platform predicts clinical outcomes and adverse events from morphology, providing actionable insights for patient care and therapeutic decision-making. By contextualizing findings within curated patient cohorts and comparing them against disease-defining datasets, GTL offers a deeper understanding of disease variability. The company aims to improve outcomes for every blood cancer patient through AI-driven insights from bone marrow morphology, working with trials, research, and clinical audits.
Ground Truth Labs
Ground Truth Labs (GTL) is an AI-driven company focused on decoding disease in the bone marrow. Their platform quantifies established markers and uncovers novel morphological patterns predictive of outcomes in blood cancers. GTL's technology analyzes bone marrow tissue at both slide and cell levels to measure features like fibrosis, megakaryocytes, blasts, and plasma cells, streamlining analysis and enhancing reproducibility. Their AI discovery platform predicts clinical outcomes and adverse events from morphology, providing actionable insights for patient care and therapeutic decision-making. By contextualizing findings within curated patient cohorts and comparing them against disease-defining datasets, GTL offers a deeper understanding of disease variability. The company aims to improve outcomes for every blood cancer patient through AI-driven insights from bone marrow morphology, working with trials, research, and clinical audits.